PUBLICATIONS

  1. Beh SC, Frohman EM. WEBINO and the Return of the King’s Speech. J Neurol Sci 2012;315(1-2):153-155

  2. Beh SC, Vernino S, Warnack WR. Clinical Reasoning: A 41-year-old comatose man with absent brainstem reflexes. Neurology 2012;78(7):e42-5 (with accompanying AAN podcast)

  3. Beh SC, Nations S, Pascual J, Vernino S. Ataxia and weakness in a young woman. Arch Neurol 2012;69(7):924-927

  4. Frohman AR, Schnurman Z, Conger A, Conger D, Beh S, Greenberg B, Sutter E, Calabresi PA, Balcer LJ, Frohman TC, Frohman EM. Multifocal Visual Evoked Potentials Are Influenced by Variable Contrast Stimulation in MS. Neurology 2012;79(8):797-801

  5. Blazek P, Davis SL, Greenberg BM, Conger A, Conger D, Vernino S, Beh S, Stuve O, Saidha S, Ratchford JN, Frohman T, Calabresi PA, Balcer LJ, and Frohman EM. Objective Characterization of the Relative Afferent Pupillary Defect in MS. J Neurol Sci 2012;323(1-2):193-200

  6. Beh SC, Greenberg BM, Frohman TC, Frohman EM. Transverse myelitis. Neurol Clin 2013;31:79-138

  7. Frohman TC, Davis SL, Beh S, Greenberg BM, Remington G, Frohman EM. Uhthoff’s phenomena in MS – clinical features and pathophysiology. Nat Rev Neurol 2013;9:535-540

  8. Frohman TC, Beh SC, Saidha S, Schnurman Z, Conger D, Conger A, Ratchford JN, Lopez C, Galetta SL, Calabresi PA, Balcer LJ, Green AJ, Frohman EM. Optic nerve head component responses of the multifocal electroretinogram in MS. Neurology 2013;81:1-7

  9. Beh SC, Frohman TC, Frohman EM. Isolated mammillary body involvement on MRI in Wernicke’s encephalopathy. J Neurol Sci 2013;334:172-175

  10. Beh SC, Frohman EM. The menagerie of neurology: animal signs and the refinement of clinical acumen. Neurol Clin Pract 2014;4:e1-e9

  11. Beh SC, Tehrani AS, Kheradmand A, Zee DS. Damping of monocular pendular nystagmus with vibration in a patient with multiple sclerosis. Neurology 2014;82:1380-1381

  12. Schnurman Z, Frohman TC, Beh SC, Conger D, Conger A, Saidha S, Galetta S, Calabresi PA, Green AJ, Balcer LJ, Frohman EM. Retinal architecture and mfERG optic nerve head component response characteristics in MS. Neurology 2014;82:1888-1896

  13. Beh SC, Muthusamy B, Calabresi PA, Hart J, Zee D, Patel V, Frohman EM. Hiding in plain sight: shining a spotlight on posterior cortical atrophy. Pract Neurol 2015;15(1):5-13

  14. Qureshi SS, Beh SC, Frohman TC, Frohman EM. An Update On Neuro-ophthalmology Of Multiple Sclerosis (MS): The Visual System As A Model To Study MS. Current Opinion in Neurology 2014;27:300-308

  15. Beh SC, Frohman TC, Frohman EM. Neuro-ophthalmic manifestations of cerebellar disease. 2014;32:1009-80

  16. Clough M, Millist L, Lizak N, Beh S, Frohman TC, Frohman EM, White O, Fielding J. Ocular motor measures of cognitive dysfunction in multiple sclerosis I: Inhibitory control. J Neurol 2015;262:1130-1137

  17. Clough M, Millist L, Lizak N, Beh S, Frohman TC, Frohman EM, White O, Fielding J. Ocular motor measures of cognitive dysfunction in multiple sclerosis II: Working memory. J Neurol 2015;262:1138-1147

  18. Beh SC, Frohman TC, Conger A, Conger D, Sutter EE, Frohman EM. Chapter 8: Electrophysiology of the Optic Nerve Head. In: Optical Coherence Tomography in Neurological Disease. 1st ed. Cambridge University Press, Cambridge; 2015

  19. Beh SC, Balcer LJ. Chapter 6: OCT and Low-Contrast Acuity. In: Optical Coherence Tomography in Neurological Disease. 1st ed. Cambridge University Press, Cambridge; 2015

  20. Beh SC, Frohman TC, Frohman EM. Neuro-ophthalmic manifestations of multiple sclerosis. In: Primer on Multiple Sclerosis. 2nd ed. Oxford University Press, New York; 2015

  21. Frohman A, Okuda D, Scott D, Beh S, Treadaway K, Mooi C, Shah A, Frohman T, Frohman E. Aquatic Training in MS: Neurotherapeutic Impact on Quality of Life. Ann Clin Transl Neurol 2015;2:864-872

  22. Beh SC. Review of Eye Movement Disorders in Clinical Practice. JAMA Neurol 2015;72:1380

  23. Fielding J, Clough M, Beh S, Millist L, Sears D, Frohman AN, Lizak N, Lim J, Kolbe S, Rennaker RL 2nd, Frohman TC, White OB, Frohman EM. Ocular motor signatures of cognitive dysfunction in multiple sclerosis. Nat Rev Neurol 2015;11:637-645

  24. Nolan R, Narayana K, Beh SC, Balcer LJ, Galetta SL. The utility of optical coherence tomography in the evaluation of monocular visual loss related to retinal ischemia. J Clin Neurosci 2016;26:116-121

  25. Beh SC, Frohman TC, Frohman EM. Monitoring Treatment in Multiple Sclerosis. In: Optical Coherence Tomography in Multiple Sclerosis – Clinical Applications. 1st ed. Springer International Publishing; 2016

  26. Zhovtis Ryerson L, Frohman TC, Foley J, Kister I, Weinstock-Guttman B, Tornatore G, Pandey K, Donnelly S, Pawate S, Bomprezzi R, Smith D, Kolb C, Qureshi S, Okuda D, Kalina J, Rimler Z, Green R, Monson N, Hoyt T, Bradshaw M, Fallon J, Chamot E, Bucello M, Beh S, Cutter G, Major E, Herbert J, Frohman EM. Extended interval dosing of natalizumab in multiple sclerosis. J Neurol Neurosurg Psychiatry 2016;87:885-889

  27. Frohman TC, Beh SC, Kildebeck EJ, Narayan R, Treadaway K, Greenberg B, Frohman EM. Neurotherapeutic strategies for multiple sclerosis. Neurol Clin 2016;34:483-523

  28. Kildebeck EJ, Narayan R, Nath A, Weiner H, Beh S, Calabresi PA, Steinman L, Major EO, Frohman TC, Frohman EM. The emergence of neuroepidemiology, neurovirology, and neuroimmunology: the legacies of John F. Kurtzke and Richard ‘Dick’ T. Johnson. J Neurol 2017;264:817-828

  29. Beh SC, Frohman TC, Frohman EM. Neuromyelitis Optica: Immunopathogenesis, Clinical Manifestations, and Treatments. Invited review for: Inflammatory Disorders of the Nervous System: pathogenesis, immunology, and clinical management. Springer International Publishing; 2017

  30. Beh SC, Kildebeck E, Narayan R, Desena A, Schnell D, Rowe ES, Rowe V, Burns D, Whitworth L, Frohman TC, Greenberg B, Frohman EM. High-dose methotrexate with leucovorin rescue: for monumentally severe CNS inflammatory syndromes. J Neurol Sci 2017;372:187-195

  31. Beh SC, Frohman TC, Frohman EM. Cerebellar control of eye movements. J Neuroophthalmology 2017;37:87-98 (with accompanying podcast)

  32. Meltzer E, Sguigna PV, Subei A, Beh S, Kildebeck E, Conger D, Conger A, Lucero M, Frohman BS, Frohman AN, Saidha S, Galetta S, Calabresi PA, Rennaker R, Frohman TC, Kardon RH, Balcer LJ, Frohman EM. Retinal architecture and melanopsin-mediated pupillary response characteristics: a putative pathophysiologic signature for the retino-hypothalamic tract in multiple sclerosis. JAMA Neurology 2017;74:574-582

  33. Beh SC. Temporal Evolution of the Trident and Piglet Signs of Osmotic Demyelination Syndrome. J Neurol Sci 2017;373:268-273

  34. Al-Louzi O, Sotirchos ES, Vidal-Jordana A, Beh SC, Button J, Ying HS, Balcer EM, Saidha S, Calabresi PA, Newsome SD. Characteristics of morphologic macular abnormalities in neuroimmunology practice. Mult Scler 2017;1352458517741206

  35. Beh SC. Top 5 CNS causes of dizziness. Published Oct 25, 2017 in the Neurology Times (http://www.neurologytimes.com/headache-and-migraine/top-5-cns-causes-dizziness)

  36. Beh SC. A case of vestibular migraine resolving on warfarin and topiramate. Headache 2018;58:599-600

  37. Beh SC. Horizontal direction-changing positional nystagmus and vertigo: a case of vestibular migraine masquerading as horizontal canal BPPV. Headache 2018;58:1113-1117

  38. Beh SC. Vestibular migraine: diagnostic criteria and evaluation. Published Dec 11, 2018 in the Neurology Times (https://www.neurologytimes.com/headache-and-migraine/vestibular-migraine-diagnostic-criteria-and-evaluation)

  39. Beh SC. Tourniquet-induced sciatic nerve injury: an unusual complication of coronary artery bypass graft surgery. Neurol Neurosci Res 2018;2(1):1

  40. Beh SC. Drug-related polyarthralgias with levodopa-carbidopa. Neurol Neurosci Res 2019;2(1):2

  41. Beh SC. Thrown around by the devil. Published March 25, 2019 in the Neurology Times (https://www.neurologytimes.com/nervous-system-diseases/thrown-around-devil)

  42. Beh SC, Masrour S, Smith SV, Friedman DI. Clinical characteristics of Alice in Wonderland syndrome in a cohort with vestibular migraine. Neurol Clin Pract 2018;8:389-396

  43. Beh SC, Masrour S, Smith SV, Friedman DI. The spectrum of vestibular migraine: clinical features, examination, and triggers. Headache 2019;59:727-740

  44. Beh SC. “Eye of the Tiger” in a patient with multiple sclerosis. J Neurol Sci 2019;399:1-2

  45. Conger D, Beh SC. Seeing function in structure: “incidental” eye findings on OCT in a patient with multiple sclerosis. Mult Scler Relat Disord 2019;31:72-73

  46. Beh SC. Vestibular migraine: a primer. Published November 8, 2019 in Medscape (https://www.medscape.com/viewarticle/920797)

  47. Beh SC, Friedman DI. Acute vestibular migraine treatment with non-invasive vagus nerve stimulation. Neurology 2019;93:e1715-e1719.

  48. Beh SC. Vestibular migraine: how to sort it out and what to do about it. J Neuroophthalmol 2019;39:208-219

  49. Beh SC. External trigeminal nerve stimulation: potential rescue treatment for acute vestibular migraine. Journal of the Neurological Sciences 2020;408:116550

  50. Beh SC. Non-invasive vagus nerve stimulation for nausea prevention during BPPV treatment. Neuromodulation 2020;23:886-887

  51. Beh SC. Emerging evidence for noninvasive vagus nerve stimulation for the treatment of vestibular migraine. Expert Rev Neurother 2020;20:991-993

  52. Beh SC. Nystagmus and vertigo in acute vestibular migraine attacks: response to non-invasive vagus nerve stimulation. Otol Neurotol 2021;42:e233-e236

  53. Beh SC, Chiang HS, Sanderson C. The interconnections of mal de debarquement syndrome and vestibular migraine. Laryngoscope 2021;131:e1653-e1661

  54. Mallampalli MP, Rizk HG, Kheradmand A, Beh SC, et al. Care gaps and recommendations in vestibular migraine: an expert panel summit. Front Neurol 2022 https://doi.org/10.3389/fneur.2021.812678